Ftse Mib
34.315,24
0,00%
DAX
20.246,37
-0,33%
S&P 500
6.050,61
-0,39%
NASDAQ
20.109,06
-0,32%
Bitcoin
103.700,79
-2,31%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ NextCure Inc (NXTC) NextCure Inc (NXTC) Notizie

NextCure Inc

NXTC
0,90
-0,11 (-10,89%)
18 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/12/202414:10EDGAR2Form 8-K - Current report
10/12/202414:05GLOBENextCure Announces Acceptance of IND Application for LNCB74
05/12/202413:11EDGAR2Form 8-K - Current report
26/11/202413:00GLOBENextCure to Participate in the 36th Annual Piper Sandler..
19/11/202414:05GLOBEPreclinical Data Demonstrates Anti-Siglec-15 Treatment..
15/11/202400:59EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:05GLOBENextCure Provides Business Update and Reports Third Quarter..
05/11/202422:05GLOBENextCure Reports Preclinical Data for LNCB74 and Additional..
04/10/202415:05GLOBENextCure to Give Two Presentations at Society for..
16/9/202414:05GLOBENextCure Presented Results of the Phase 1b Study of NC410 in..
01/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:10EDGAR2Form 8-K - Current report
01/8/202422:05GLOBENextCure Provides Business Update and Reports Second Quarter..
20/6/202422:10GLOBENextCure to Present at the H.C. Wainwright 5th Annual Neuro..
18/6/202422:10EDGAR2Form 8-K - Current report
30/5/202422:05GLOBENextCure Presents Phase 1b Data on NC410 and Pembrolizumab..
02/5/202422:05GLOBENextCure Provides Business Update and Reports First Quarter..
24/4/202422:05GLOBENextCure to Present Phase 1b Data of NC410 in Combination..
08/4/202413:00GLOBENextCure and LCB Present Preclinical Data on B7-H4 Antibody..
04/4/202413:05GLOBENextCure Appoints Dr. Rakesh Dixit to Scientific Advisory..
02/4/202413:00GLOBENextCure to Present at 23rd Annual Needham Virtual..
21/3/202413:55GLOBENextCure Provides Business Update and Reports Full Year 2023..
05/3/202414:05GLOBENextCure Publishes Preclinical Data Demonstrating Function..
01/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202422:05GLOBENextCure Presents Preclinical Data on a Novel Therapeutic..
21/12/202313:05GLOBENextCure Publishes Non-Clinical Data Demonstrating..
Apertura: 1,01 Min: 0,894 Max: 1,03
Chiusura: 1,01

La tua Cronologia

NASDAQ
NXTC
NextCure
BOV
GDBR34Q
Gen Dynamics DRN
USOTC
UVPOF
Univanich Palm Oil Publi... (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network